search
Back to results

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention (TaiPEI)

Primary Purpose

Dementia

Status
Recruiting
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
multi-modal non-pharmacological intervention
Sponsored by
Taipei Medical University Shuang Ho Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dementia

Eligibility Criteria

60 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. People over 60 without dementia
  2. Agree to join the study and sign the consent form
  3. The Modified Rankin Scale (MRS) scores between 0-1 points
  4. Education level: elementary or higher education (6 years) or can read and write Chinese
  5. Very early dementia screening scale (AD-8) < 2, or more than 2 points but without dementia diagnoses after refer to a neurologist.
  6. Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) Risk Score: above 8; diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD) in the past six months.

Exclusion Criteria:

  1. Have been diagnosed with any kind of dementia
  2. Suspected dementia patients or others who are not suitable to participate in the research assessed by a doctor at the first visit
  3. Diseases affecting the safety of various interventional activities (such as remaining life less than two years, symptomatic heart/cerebrovascular disease within 6 months, vascular reperfusion or reconstruction-related surgery within one year, etc., malignant tumor within one year)
  4. Severe blindness, hearing or communication impairment, or other difficulty in cooperating or completing assessments and interventions (especially exercise) in the study
  5. Severe mental illnesses, including major depression disorder, or major neuromusculoskeletal disorders that are not suitable to join the study.
  6. Drug or alcohol abuse in the last year
  7. Overlapping with other interventional trials at the same time which may affect the evaluation results.

Sites / Locations

  • Taipei Medical University-Shuang Ho HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Placebo Comparator

Arm Label

On-site

Remote

Control

Arm Description

The on-site multi-modal intervention will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol.

The remote intervention group is designed for reducing the chances of person-to-person contact response to the current COVID-19 pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs.

The control group will also receive the same health evaluation and education as all intervention groups.

Outcomes

Primary Outcome Measures

Change in cognition including individual cognitive domains, unit on a scale
A composite z-score will be obtained from the neuropsychological tests evaluating multiple cognitive domains, including memory, language, process speed, visuospatial, and executive function.

Secondary Outcome Measures

Change in physical assessment, unit on a scale
Senior Fitness Test (SFT) measures six functional areas of physical function (strength, endurance, balance, agility, and flexibility)
Change in physical assessment, unit on a scale
Short Physical Performance Battery (SPPB), score range: 0-12; higher scores mean a better outcome.
Change in physical assessment, unit on a scale
International Physical Activity Questionnaire (IPAQ), a 27-item self-reported measure of physical activity
Change in physical functioning - Hand-grip strength, kg
Measured using a hand-grip dynamometer
Change of the questionnaire regarding the nutrition, unit on a scale
Mini Nutritional Assessment-Short Form (MNA-SF), a screening scale used to assess current nutritional status. score range: 0-14, higher scores mean a better outcome.
Change of the questionnaire regarding the nutrition, unit on a scale
food frequency questionnaire (FFQ), a finite list of foods and beverages with response categories to indicate usual frequency of consumption over the time period
Change of nutrition intake, unit on a scale
3-day dietary record: a self-reported account of all foods and beverages consumed within recent three days
Change in functioning level, unit on a scale
Activities of Daily Living Questionnaire (ADLQ)
Change in functioning level, unit on a scale
The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment (UPSA-Brief) -Traditional Chinese Version: two subdomains (Finances, Communication) with a total score ranging from 0 to 100.
Change in functioning level, unit on a scale
Florida Cognitive Activities Scale (FCAS): a 25-item scale used to assess cognitive activities in the elderly with two subscales (Higher Cognitive Abilities and Frequent Cognitive Abilities)
Change in functioning level, unit on a scale
EuroQol five-dimensional (EQ-5D): an instrument for measuring quality of life regarding the five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Change in functioning level, unit on a scale
Activities of Daily Living Questionnaire (ADLQ), The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment(Traditional Chinese Version)(UPSA-Brief), Florida Cognitive Activities Scale(FCAS), EuroQol five-dimensional (EQ-5D)
Change in depressive symptoms, unit on a scale.
Geriatric Depression Scale-Short Form (GDS-S), score range: 0-15; higher scores mean a worse outcome.
Change in sleep symptoms, unit on a scale.
Epworth sleepiness scale (ESS)
Change in sleep symptoms, unit on a scale.
Pittsburgh Sleep Quality Index (PSQI)
Change in blood tests - fasting plasma glucose, mmol/L.
Measured from fasting blood sample
Change in blood tests - triglycerides, mmol/L.
Measured from fasting blood sample
Change in blood tests - Albumin, prealbumin, g/dL.
Measured from fasting blood sample
Change of Plasma amyloid beta, pg/mL
Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),
Change of Plasma tau, pg/mL
Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),

Full Information

First Posted
January 31, 2022
Last Updated
October 27, 2022
Sponsor
Taipei Medical University Shuang Ho Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05407857
Brief Title
Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention
Acronym
TaiPEI
Official Title
Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention (TaiPEI)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2022 (Actual)
Primary Completion Date
December 2026 (Anticipated)
Study Completion Date
December 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Taipei Medical University Shuang Ho Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
A 3-arm randomized controlled trial of multi-modal non-pharmacological Intervention for preventing the risk of dementia in Taiwanese geriatric people
Detailed Description
This project proposes an intervention program for dementia prevention based on the Taiwanese model. The investigator(s) will screen the elderly who are not yet demented but are at high risk of dementia and will randomly allocate them into three groups (on site intervention group, remote intervention group, and control group) for a two-year multi-modal non-pharmacological intervention. All intervention groups will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol. The remote intervention group is designed for reducing the chances of person-to-person contact response to the current coronavirus disease 2019 (COVID-19) pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs. During the study period, each group will be regularly monitored the changes of cardiovascular risk factors, physical performance and cognitive function. The results of multimodal intervention mainly from Taipei and New Taipei City will establish the Taiwan FINGER model (TaiPEI) and will have the information of the conditions and feasibility achieved in Taiwan and implementation suggestions in the face of the epidemic. It can be subsequently applied to the brain/body health care institution and to the prevention of dementia and cardiovascular disease of elderly.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Three groups (on site intervention group, remote intervention group, and control group)
Masking
Outcomes Assessor
Masking Description
We will avoid all the outcomes assessors knowing the allocation and intervention groups. The participant will only know what treatment is applied until the start of the intervention. We will also suggest the participants not to discuss their interventions and restrict the chance of communication between different intervention groups.
Allocation
Randomized
Enrollment
380 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
On-site
Arm Type
Experimental
Arm Description
The on-site multi-modal intervention will be actively involved in management with nutrition, exercise and cognitive programs. The on-site intervention group requires subjects to participate in prescribed place according to the protocol.
Arm Title
Remote
Arm Type
Active Comparator
Arm Description
The remote intervention group is designed for reducing the chances of person-to-person contact response to the current COVID-19 pandemic and development of digital internet. It uses innovative technology combining wearable devices with inertial measurement units, blue-tooth equipment, apps, feedback technology and artificial intelligence based remote comprehensive training programs.
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
The control group will also receive the same health evaluation and education as all intervention groups.
Intervention Type
Behavioral
Intervention Name(s)
multi-modal non-pharmacological intervention
Intervention Description
multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs
Primary Outcome Measure Information:
Title
Change in cognition including individual cognitive domains, unit on a scale
Description
A composite z-score will be obtained from the neuropsychological tests evaluating multiple cognitive domains, including memory, language, process speed, visuospatial, and executive function.
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Secondary Outcome Measure Information:
Title
Change in physical assessment, unit on a scale
Description
Senior Fitness Test (SFT) measures six functional areas of physical function (strength, endurance, balance, agility, and flexibility)
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in physical assessment, unit on a scale
Description
Short Physical Performance Battery (SPPB), score range: 0-12; higher scores mean a better outcome.
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in physical assessment, unit on a scale
Description
International Physical Activity Questionnaire (IPAQ), a 27-item self-reported measure of physical activity
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in physical functioning - Hand-grip strength, kg
Description
Measured using a hand-grip dynamometer
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change of the questionnaire regarding the nutrition, unit on a scale
Description
Mini Nutritional Assessment-Short Form (MNA-SF), a screening scale used to assess current nutritional status. score range: 0-14, higher scores mean a better outcome.
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change of the questionnaire regarding the nutrition, unit on a scale
Description
food frequency questionnaire (FFQ), a finite list of foods and beverages with response categories to indicate usual frequency of consumption over the time period
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change of nutrition intake, unit on a scale
Description
3-day dietary record: a self-reported account of all foods and beverages consumed within recent three days
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in functioning level, unit on a scale
Description
Activities of Daily Living Questionnaire (ADLQ)
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in functioning level, unit on a scale
Description
The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment (UPSA-Brief) -Traditional Chinese Version: two subdomains (Finances, Communication) with a total score ranging from 0 to 100.
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in functioning level, unit on a scale
Description
Florida Cognitive Activities Scale (FCAS): a 25-item scale used to assess cognitive activities in the elderly with two subscales (Higher Cognitive Abilities and Frequent Cognitive Abilities)
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in functioning level, unit on a scale
Description
EuroQol five-dimensional (EQ-5D): an instrument for measuring quality of life regarding the five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in functioning level, unit on a scale
Description
Activities of Daily Living Questionnaire (ADLQ), The Brief University of California San Diego (UCSD) Performance-Based Skills Assessment(Traditional Chinese Version)(UPSA-Brief), Florida Cognitive Activities Scale(FCAS), EuroQol five-dimensional (EQ-5D)
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in depressive symptoms, unit on a scale.
Description
Geriatric Depression Scale-Short Form (GDS-S), score range: 0-15; higher scores mean a worse outcome.
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in sleep symptoms, unit on a scale.
Description
Epworth sleepiness scale (ESS)
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in sleep symptoms, unit on a scale.
Description
Pittsburgh Sleep Quality Index (PSQI)
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in blood tests - fasting plasma glucose, mmol/L.
Description
Measured from fasting blood sample
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in blood tests - triglycerides, mmol/L.
Description
Measured from fasting blood sample
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change in blood tests - Albumin, prealbumin, g/dL.
Description
Measured from fasting blood sample
Time Frame
Before intervention (Baseline); During intervention (every six month); follow-up (6 months after intervention ends)
Title
Change of Plasma amyloid beta, pg/mL
Description
Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),
Time Frame
Before intervention (Baseline); During intervention (6th month and 24th month)
Title
Change of Plasma tau, pg/mL
Description
Assessed by ultra-sensitive, immunomagnetic reduction assay (MagQu, LLC, Surprise, AZ),
Time Frame
Before intervention (Baseline); During intervention (6th month and 24th month)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: People over 60 without dementia Agree to join the study and sign the consent form The Modified Rankin Scale (MRS) scores between 0-1 points Education level: elementary or higher education (6 years) or can read and write Chinese Very early dementia screening scale (AD-8) < 2, or more than 2 points but without dementia diagnoses after refer to a neurologist. Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) Risk Score: above 8; diagnosed with mild cognitive impairment (MCI) or subjective cognitive decline (SCD) in the past six months. Exclusion Criteria: Have been diagnosed with any kind of dementia Suspected dementia patients or others who are not suitable to participate in the research assessed by a doctor at the first visit Diseases affecting the safety of various interventional activities (such as remaining life less than two years, symptomatic heart/cerebrovascular disease within 6 months, vascular reperfusion or reconstruction-related surgery within one year, etc., malignant tumor within one year) Severe blindness, hearing or communication impairment, or other difficulty in cooperating or completing assessments and interventions (especially exercise) in the study Severe mental illnesses, including major depression disorder, or major neuromusculoskeletal disorders that are not suitable to join the study. Drug or alcohol abuse in the last year Overlapping with other interventional trials at the same time which may affect the evaluation results.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yi-Chun Kuan, MD
Phone
+886-222490088
Ext
8112
Email
yckuang2@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yi-Chun Kuan, MD
Organizational Affiliation
Taipei Medical University Shuang Ho Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Taipei Medical University-Shuang Ho Hospital
City
New Taipei City
ZIP/Postal Code
235
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yi-Chun Kuan
Phone
0970747553
Email
yckuang2@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention

We'll reach out to this number within 24 hrs